- Home
- TNGX vs GDEV Comparison
TNGX vs GDEV Comparison
Compare TNGX & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- GDEV
- Stock Information
- Founded
- TNGX 2014
- GDEV 2009
- Country
- TNGX United States
- GDEV Cyprus
- Employees
- TNGX N/A
- GDEV N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- TNGX Health Care
- GDEV Technology
- Exchange
- TNGX Nasdaq
- GDEV Nasdaq
- Market Cap
- TNGX 317.4M
- GDEV N/A
- IPO Year
- TNGX N/A
- GDEV N/A
- Fundamental
- Price
- TNGX $1.76
- GDEV $15.24
- Analyst Decision
- TNGX Strong Buy
- GDEV Buy
- Analyst Count
- TNGX 7
- GDEV 2
- Target Price
- TNGX $12.33
- GDEV $70.00
- AVG Volume (30 Days)
- TNGX 801.9K
- GDEV 33.5K
- Earning Date
- TNGX 05-07-2025
- GDEV 04-01-2025
- Dividend Yield
- TNGX N/A
- GDEV N/A
- EPS Growth
- TNGX N/A
- GDEV N/A
- EPS
- TNGX N/A
- GDEV 2.04
- Revenue
- TNGX $42,069,000.00
- GDEV $432,534,000.00
- Revenue This Year
- TNGX N/A
- GDEV N/A
- Revenue Next Year
- TNGX N/A
- GDEV $9.01
- P/E Ratio
- TNGX N/A
- GDEV $7.45
- Revenue Growth
- TNGX 15.17
- GDEV N/A
- 52 Week Low
- TNGX $1.71
- GDEV $14.26
- 52 Week High
- TNGX $12.02
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- TNGX 33.97
- GDEV 41.01
- Support Level
- TNGX $1.80
- GDEV $14.43
- Resistance Level
- TNGX $2.04
- GDEV $19.50
- Average True Range (ATR)
- TNGX 0.18
- GDEV 0.89
- MACD
- TNGX 0.01
- GDEV -0.30
- Stochastic Oscillator
- TNGX 20.19
- GDEV 15.54
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.